Healthcare – Page 2 – The Media Pub News

US Food and Drug Administration approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) injection, for subcutaneous use in most previously approved adult, solid tumor Opdivo® (nivolumab) indications1,2

December 28, 2024

Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given over three- to five-minutes, Opdivo Qvantig demonstrated consistent efficacy and showed a comparable safety profile tointravenous Opdivo in the Phase 3 CheckMate-67T trial1,3 PRINCETON, N.J. — (BUSINESS WIRE)

Business, Cultural Corner, Healthcare

Extra holiday cheer for workers at New Jersey cannabis dispensary Flower & Flame after successful vote to unionize

December 23, 2024

Joining United Food and Commercial Workers Local 360 gives employees more say, opens access to more training and development, brings expanded benefits options, and more. WEST BERLIN, N.J. — (BUSINESS WIRE) — #blackwood — United Food and Commercial Workers (UFCW)

Business, Healthcare, Science

Knipper Health announces transfer of commercial sample management business from Thermo Fisher Scientific

December 19, 2024

LAKEWOOD, N.J. — (BUSINESS WIRE) — Knipper Health, Inc., the largest supplier of end-to-end pharmaceutical healthcare marketing services and solutions in the U.S. serving the biopharmaceutical and medical industries, announced today the Company has been assigned the assets of Patheon Pharma Services

Healthcare, Local News, Science

Catalent and Novo Holdings fulfill all regulatory closing conditions for pending transaction

December 19, 2024

Transaction expected to close in the coming days SOMERSET, N.J. & COPENHAGEN, Denmark — (BUSINESS WIRE) — Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (“Novo

Business, Healthcare, Science

Newron and EA Pharma (a subsidiary of Eisai Co., Ltd.) announce license agreement for Evenamide in Japan and other Asian territories

December 19, 2024

Ad hoc announcement pursuant to Art. 53 LR Newron will receive up to a maximum of €117 million from an upfront payment, development milestones and commercialization milestones, and up to double-digit tiered royalties on net sales Evenamide is a unique modulator of

Business, Cultural Corner, Healthcare

Prudential collaborates with Empathy to enhance workplace benefits with holistic bereavement support for families coping with loss

December 18, 2024

Prudential Group Insurance expands suite of resources and services for beneficiaries to help navigate the emotional and practical challenges that come with the loss of a loved one. NEWARK, N.J. — (BUSINESS WIRE) — The loss of a loved one is a

Business, Healthcare, Science

Fonseca Biosciences secures exclusive US rights to XTORO® (finafloxacin otic suspension) 0.3 percent to treat ‘swimmer’s ear’

December 14, 2024

XTORO is a new chemical entity that is FDA approved for the treatment of acute otitis externa, commonly known as “swimmer’s ear,” caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus LONG BEACH TOWNSHIP, N.J. — (BUSINESS WIRE) — Fonseca Biosciences

Business, Healthcare, Technology

From challenges to opportunities: Majesco maps key trends in 2025 Shaping the Future of Insurance

December 14, 2024

MORRISTOWN, N.J. — (BUSINESS WIRE) — Majesco, a global leader in cloud insurance software solutions, Tuesday announced the release of its latest Thought Leadership report, 8 Trends Shaping the Future of Insurance in 2025, an annual report highlighting trends for the next

Cultural Corner, Healthcare, Science

Wedgewood launches Blue Rabbit for equine veterinarians at AAEP

December 05, 2024

SWEDESBORO, N.J. — (BUSINESS WIRE) — #BlueRabbit — Wedgewood Equine, a dedicated division of Wedgewood, the nation’s largest provider of compounded veterinary medications, is excited to unveil Blue Rabbit for equine veterinarians at this year’s American Association of Equine Practitioners (AAEP) 70th